PYPD
PYPD
NASDAQ · Pharmaceuticals

Polypid Ltd

$5.17
-0.04 (-0.77%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +629.4% upside
Low Target $24.55
Average Target $37.71
High Target $48.03
Current Price $5.17
Current
$5.17
Target
$37.71
$24.55 $37.71 avg $48.03
Scenario Analysis
Bear Case
$24.55
374.9%
Low target
Base Case
$37.71
+629.4%
Avg target
Bull Case
$48.03
+829.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.73
-9.8% from high
52-Week Low
$3.06
+69.0% from low
Target vs 52W High
$37.71
+558.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%